Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13675268 | 0.91 | OXTR (0.32) | OXTRMAPT | |
| SCHEMBL1653268 | 0.74 | MAPT (0.33) | OXTRMAPT | |
| SCHEMBL1654129 | 0.71 | MAPT (0.33) | OXTRMAPT | |
| SCHEMBL13360075 | 0.70 | MAPT (0.34) | OXTRMAPT | |
| SCHEMBL13360038 | 0.69 | MAPT (0.32) | OXTRMAPT | |
| SCHEMBL13348504 | 0.69 | CNR1 (0.32) | OXTRMAPT | |
| SCHEMBL13221728 | 0.67 | ALDH1A1 (0.36) | MAPT | |
| SCHEMBL13675013 | 0.67 | MAPT (0.35) | OXTRMAPT | |
| SCHEMBL13222041 | 0.67 | MEN1 (0.34) | MAPT | |
| SCHEMBL13348392 | 0.67 | MAPT (0.32) | OXTRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090247746-A1 | Fused heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247746-A1 | Fused heterocyclic compound | GCKR, GCK, GPR119 | OXTR 2624/4885MAPT 4377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.